We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Other cookies are those that are being identified and have not been classified into any category as yet.
23rd August 2018 – A joint collaboration between the John Montgomery’s Group at the University of Michigan and an ICIQ researcher has resulted in the development of a new class of Nickel (0) catalysts, which will expedite a broad range of organic reactions.
These new compounds, published in the American Chemical Society journal, ACS Catalysis with a patent pending, provide rare examples of Nickel (0) complexes that tolerate air exposure while maintaining high catalytic activities for the construction of strategic bonds in medicinal chemistry. This feature avoids the need to use an inert atmosphere glovebox, making their use more sustainable and user-friendly.
“We hope these catalysts can make the synthesis of new drug candidates easier, cheaper and more sustainable” explains Santiago Cañellas, a predoctoral researcher in the Pericàs Group involved in the project. Three of these catalysts can be now purchased from Strem Chemicals, Inc.
Join our team to work with renowned researchers, tackle groundbreaking
projects and contribute to meaningful scientific advancements